These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 7029838)
41. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
42. Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Hong Kong Chest Service/British Medical Research Council. Am Rev Respir Dis; 1987 Dec; 136(6):1339-42. PubMed ID: 2891333 [TBL] [Abstract][Full Text] [Related]
43. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens. Jawahar MS; Rajaram K; Sivasubramanian S; Paramasivan CN; Chandrasekar K; Kamaludeen MN; Thirithuvathas AJ; Ananthalakshmi V; Prabhakar R Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733 [TBL] [Abstract][Full Text] [Related]
44. [Short-term chemotherapy of tuberculosis. Cooperative French trial]. Pretet S Rev Fr Mal Respir; 1983; 11(6):859-66. PubMed ID: 6366945 [TBL] [Abstract][Full Text] [Related]
45. Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial. Jindani A; Nunn AJ; Enarson DA Lancet; 2004 Oct 2-8; 364(9441):1244-51. PubMed ID: 15464185 [TBL] [Abstract][Full Text] [Related]
46. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment]. Berkani M; Chaulet P; Darbyshire JH; Nunn A; Fox W Rev Mal Respir; 1986; 3(2):73-85. PubMed ID: 3726263 [TBL] [Abstract][Full Text] [Related]
47. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis]. Zierski M; Bek E Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146 [No Abstract] [Full Text] [Related]
48. Short-course antituberculous chemotherapy for pulmonary and pleural disease: 5 years' experience in clinical practice. Ormerod LP; Horsfield N Br J Dis Chest; 1987 Jul; 81(3):268-71. PubMed ID: 3663498 [TBL] [Abstract][Full Text] [Related]
49. [Short term chemotherapy of tuberculosis. Evaluation of an 18-week-long treatment including pyrazinamide (preliminary results)]. Pretet S; Grosset J; Perdrizet S Bull Int Union Tuberc; 1978 Dec; 53(4):260-1. PubMed ID: 387140 [No Abstract] [Full Text] [Related]
50. Controlled clinical trial of a regimen of two durations for the treatment of isoniazid resistant pulmonary tuberculosis. Babu Swai O; Aluoch JA; Githui WA; Thiong'o R; Edwards EA; Darbyshire JH; Nunn AJ Tubercle; 1988 Mar; 69(1):5-14. PubMed ID: 3051607 [TBL] [Abstract][Full Text] [Related]
51. [Six-months chemotherapy (2HRZS or E/4HRE) of new cases of pulmonary tuberculosis--six year experiences on its effectiveness, toxicity, and acceptability]. Wada M; Yoshiyama T; Ogata H; Ito K; Mizutani S; Sugita H Kekkaku; 1999 Apr; 74(4):353-60. PubMed ID: 10355221 [TBL] [Abstract][Full Text] [Related]
52. A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen. Cohn DL; Catlin BJ; Peterson KL; Judson FN; Sbarbaro JA Ann Intern Med; 1990 Mar; 112(6):407-15. PubMed ID: 2106816 [TBL] [Abstract][Full Text] [Related]
53. [Comparison of a 6-month chemotherapy and a l2-month chemotherapy in the treatment of pulmonary tuberculosis in Algerian Sahara. Cooperative study by an Algerian work team and the British Medical Research Council]. Chaulet P Bull Int Union Tuberc; 1985; 60(1-2):31-3. PubMed ID: 4074970 [No Abstract] [Full Text] [Related]
54. Treatment of childhood tuberculosis with a six month directly observed regimen of only two weeks of daily therapy. Al-Dossary FS; Ong LT; Correa AG; Starke JR Pediatr Infect Dis J; 2002 Feb; 21(2):91-7. PubMed ID: 11840073 [TBL] [Abstract][Full Text] [Related]
55. Comparison of a daily and three intermittent retreatment regimens for pulmonary tuberculosis administered under programme conditions. Hong YP; Kim SC; Chang SC; Kim SJ; Jin BW; Park CD Tubercle; 1988 Dec; 69(4):241-53. PubMed ID: 3076999 [TBL] [Abstract][Full Text] [Related]